Primary FDA-Approved Indications
Short‑term therapy improves symptoms and healing in erosive esophagitis; once‑daily dosing is standard.
GERD (symptomatic)
FDA ApprovedChildren and adolescentsLabelFirst-line
Lifestyle measures alongside medication.
Treatment Duration
Standard: 4–8 weeks
Evidence Sources
Omeprazole — DailyMed ()
Erosive esophagitis
FDA ApprovedChildren and adolescentsLabelFirst-line
Per label; evaluate maintenance need.
Treatment Duration
Standard: Up to 8 weeks
Evidence Sources
Omeprazole — DailyMed ()